RyMed Technologies, LLC specializes in the development and marketing of innovative safety products for intravenous catheter management. RyMed's products are designed to reduce the two most critical vascular access catheter complications of Catheter-related Bloodstream Infections (CR-BSI) and Intraluminal Thrombotic Catheter Occlusions. RyMed manufactures and distributes the InVision-Plus® needleless connector with Neutral Advantage™ Technology and the InVision-Plus CS--the only needleless connector treated with Chlorhexidine and Silver. RyMed's Neutral Advantage Technology meets a 10-Point Standard; ten features designed to work together to maximize intraluminal catheter protection and prevent catheter-related bloodstream infections (CR-BSIs). RyMed also represents PICC Guard, the only FDA cleared Tamper-Evident and Tamper Resistant technology. PICC Guard can address your opioid epidemic concerns while providing patient centered care.